Company / AR per Share
Tarsus Pharmaceuticals, Inc. AR per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$2.22
FY2025
5-year range
$0.62 / $2.22
FY2023-FY2025
Trend
+62.3%
vs FY2024
Sector context
#40 of 113
Health Care
What the data says
At $2.22, Tarsus Pharmaceuticals, Inc.'s ar per share ranks #40 of 113 in the Health Care sector. Improved from $0.62 to $2.22 over the past 2 years.
Based on SEC 10-K filings.
2.22 in FY2025.
Improved from $0.62 to $2.22 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#40 of 113 in Health CareTop 35% of 113This company $2.22 Sector average $28.83
▼
-92.3% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 62.3% year-over-year.
- Ranks #40 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.22 | +62.3% |
| FY2024 | $1.37 | +119.6% |
| FY2023 | $0.62 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026